Skip to main content

QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the third quarter of 2022.

Press release date / time: Monday, November 7, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Tuesday, November 8, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.

Three options for joining the conference call

Register for call back connection

 

Click here:

Connect me

 

Service available 15 minutes before call start

Dial-in by phone

 

 

+1 646 828 8073 (U.S.)

+44 (0)330 165 4012 (UK)

+49 (0)69 22222 5197 (GER)

 

To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.

 

Conference ID: 6981929

 

Access the audio webcast

 

Click here:

Access Webcast

A conference call replay will be available by using the following link:

https://globalmeet.webcasts.com/starthere.jsp?ei=1565383&tp_key=5dca096fdf

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of June 30, 2022, QIAGEN employed more than < 6,100 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

Contacts

John Gilardi

Vice President, Head of Corporate Communications and Investor Relations

+49 2103 29 11711

+1 240 686 2222

Email: ir@qiagen.com

Phoebe Loh

Senior Director Investor Relations

+49 2103 29 11457

Email: ir@qiagen.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.